Pharmaceutical giant Pfizer, the largest drug company in the world, has disclosed that it paid approximately $20 million in consulting and speaking fees to 4,500 doctors and medical professionals during the last half of 2009. Pfizer also paid $15.3 million during the same period to 250 medical centers and research groups conducting clinical trials. Most [...]
The U.S. Food and Drug Administration is considering whether to stop a safety study comparing Avandia to another diabetes medication. If the study is stopped, it is possible that the FDA will remove the drug from the market. It has been estimated that more than 200,000 people in the U.S. alone suffer serious, sometimes even [...]
It is becoming increasingly common for patients and their families to use complicated medical devices at home—devices such as infusion pumps and IV machines, dialysis machines, and even ventilators. They may be used to treat a chronic condition or to continue post-operative care at home. The U.S. Food and Drug Adminstration has called for increased [...]
Drug manufacturer Hospira Inc. has acknowledged receiving a warning letter from the U.S. Food and Drug Administration (FDA) after the FDA officials discovered manufacturing problems at two Hospira manufacturing facilities. Inspectors found that Hospira’s emulsion products being produced at Rocky Mount and Clayton, North Carolina did not meet manufacturing standards. At the Rocky Mount facilities, [...]